Hormone levels change with aging, menopause, andropause, surgical removal of ovaries or testes, certain medications, and medical conditions. Symptoms can include hot flashes, night sweats, poor sleep, low libido, erectile difficulty, vaginal dryness, brain fog, loss of muscle, increased body fat, low mood, and reduced exercise recovery. Those symptoms have more than one cause. Hormone replacement is considered when history, exam, and labs support a deficiency or a menopausal indication—not because a birthday or a marketing panel says “optimize.”
Helix Advanced Medicine treats men and women. We use traditional FDA-approved hormone therapy and bioidentical hormone replacement, including pellet therapy, when a clinician determines it is appropriate. The hormone, the dose, and the delivery method are separate decisions.
“Bioidentical” means the hormone molecule matches what the body produces (for example, estradiol, micronized progesterone, or testosterone). That chemistry can come as an FDA-approved product or as a compounded preparation, including pellets. Pellets are a delivery system, not a different hormone class and not automatically safer.
Who this program may be for
- Women: perimenopause or menopause with vasomotor symptoms, sleep disruption, or genitourinary symptoms; premature or surgical menopause; selected patients who may benefit from estradiol with appropriate progestogen if the uterus is present; selected women with low testosterone symptoms after estrogen status is addressed
- Men: confirmed hypogonadism (symptoms plus repeatedly low morning testosterone) — not “low T advertising” based on a single afternoon lab or nonspecific fatigue alone
Hormone therapy is not appropriate for everyone. History of certain cancers, unexplained bleeding, active blood clots, untreated sleep apnea (especially before testosterone), poorly controlled cardiovascular disease, and other conditions can change or prohibit treatment. Eligibility is determined after evaluation.
Evaluation before any prescription
A Helix hormone visit typically includes symptom and goal review; medical, surgical, cancer, clot, and family history; medication and supplement list; targeted exam; baseline labs appropriate to sex and indication; and breast, cervical, prostate, and cardiovascular screening status as relevant. We do not start pellets—or any HRT—on symptoms alone without a documented plan for dose, monitoring, and follow-up.
Treatment options we use
Traditional FDA-approved hormone therapy uses regulated products with standardized dosing. For women: estradiol patches, gels, sprays, or oral therapy; micronized progesterone or other progestogens when a uterus is present; vaginal estrogen for local symptoms. For men: testosterone cypionate or enanthate injections, gels, patches, or other approved formulations. Advantages include known dosing, easier titration, product quality standards, and a large evidence base for menopausal estrogen/progestogen regimens.
When we use the term bioidentical, we mean estradiol, progesterone, and testosterone in forms chemically identical to human hormones. That includes FDA-approved bioidentical products and compounded preparations when a standard product cannot meet a specific clinical need.
Pellets are small implants placed under the skin (usually the hip or buttock) that release hormone over months. Helix may use estradiol and/or testosterone pellets for selected women, and testosterone pellets for selected men. Insertion is a minor office procedure after consent. Timing of repeat insertion depends on symptoms and follow-up labs, not a fixed calendar alone. Compounding is a tool for customization, not a claim of superiority.
How we approach men and women differently
Women: estrogen therapy is most often used for menopausal symptoms and for selected younger women after menopause or oophorectomy. If the uterus is present, a progestogen (commonly micronized progesterone) is included to protect the endometrium. Testosterone, including female-dose pellets, is considered only when indicated after estrogen is addressed. Risks that must be discussed include blood clots, stroke, gallbladder disease, and breast-cancer risk that depends on the regimen, duration, and the woman’s baseline risk.
Men: testosterone is prescribed for documented hypogonadism. Delivery may be injection, gel, or pellets. Monitoring includes symptoms, testosterone level, hematocrit/hemoglobin, and prostate evaluation appropriate to age and history.
Monitoring after treatment starts
- Symptom check and bloodwork after initiation or a new pellet insertion
- Interval labs, including blood count on testosterone
- Blood-pressure and cardiovascular risk review
- Breast, bleeding, and prostate surveillance as indicated
- Dose change, method change, or discontinuation when risks outweigh benefit
What hormone therapy is not
- Not a treatment for dementia, obesity, or “anti-aging” as a diagnosis
- Not a substitute for sleep, resistance training, protein intake, or treatment of thyroid or depression
- Not risk-free because it is labeled bioidentical or given as a pellet
- Not appropriate without labs, consent, and a monitoring schedule
What to expect at Helix Advanced Medicine
- 01Consultation — symptoms, goals, history, and prior hormone use
- 02Labs and screening review
- 03Shared decision — traditional product vs bioidentical option vs pellets, with risks and follow-up in writing
- 04Start of therapy — prescription and/or pellet insertion when indicated
- 05Follow-up — symptoms, labs, and decision to continue, convert, or stop
